Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Cancer (Primary and Metastatic)”

206 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 206 results

Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Not applicableUnknownNCT05183425
What this trial is testing

Patient-derived Organoids Predicts the Clinical Efficiency of Colorectal Liver Metastasis

Who this might be right for
Explore the Consistency of Drug Sensitivity Between Primary Colorectal Cancer and Liver Metastases
Changhai Hospital 60
Large-scale testing (Phase 3)Study completedNCT00307866
What this trial is testing

Identification of Hepatic Lesions

Who this might be right for
Hepatic Neoplasms
Bayer 218
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07684040
What this trial is testing

Combination Therapy in Patients With Resectable Liver Cancer

Who this might be right for
Liver Cancer (Primary and Metastatic)
Affiliated Hospital of Guangdong Medical University 68
Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00128596
What this trial is testing

Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
University of Pittsburgh 25
Early research (Phase 1)Study completedNCT00030082
What this trial is testing

Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Liver CancerMetastatic Cancer
National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT07369505
What this trial is testing

Sapu003 in Advanced mTOR-sensitive Solid Tumors

Who this might be right for
Breast Cancer MetastaticRenal Cell Carcinoma (RCC)Neuroendocrine Tumors+2 more
SAPU NANO (US) LLC 27
Testing effectiveness (Phase 2)Study completedNCT00238394
What this trial is testing

Cediranib Maleate in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer
National Cancer Institute (NCI) 44
Not applicableLooking for participantsNCT05714124
What this trial is testing

Liver Embolization Approaches for Tumor Management

Who this might be right for
Hepatocellular CarcinomaCholangiocarcinomaMetastatic Colon Cancer+4 more
IRCCS San Raffaele 580
Testing effectiveness (Phase 2)Study completedNCT00511862
What this trial is testing

TheraSphere for the Treatment of Liver Metastases

Who this might be right for
Colorectal CancerCarcinoma, NeuroendocrineNeoplasm Metastasis
Boston Scientific Corporation 151
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Large-scale testing (Phase 3)Looking for participantsNCT03895359
What this trial is testing

Transarterial Chemoembolization (TACE) Versus TACE Plus Stereotactic Body Radiation Therapy (SBRT) in Liver Carcinoma

Who this might be right for
Hepatocellular Carcinoma
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 128
Not applicableStudy completedNCT07631611
What this trial is testing

Organ-Specific Differences in Immunotherapy Response Among Metastatic Cancer Patients

Who this might be right for
Solid TumorsMetastatic Cancer to LiverMetastatic Cancer to the Bone+5 more
Wenlong Zhong, MD 938
Early research (Phase 1)Ended earlyNCT04187872
What this trial is testing

LITT and Pembrolizumab in Recurrent Brain Metastasis

Who this might be right for
MelanomaNon-small Cell Lung Carcinoma (NSCLC)Renal Cell Carcinoma (RCC)+12 more
University of Florida 10
Not applicableWithdrawnNCT04985357
What this trial is testing

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

Who this might be right for
Stage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more
Travera Inc
Early research (Phase 1)Study completedNCT00031681
What this trial is testing

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more
National Cancer Institute (NCI) 41
Early research (Phase 1)Study completedNCT01643499
What this trial is testing

Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasAdenocarcinoma of the GallbladderAdenocarcinoma of Unknown Primary+37 more
University of Chicago 79
Post-approval studies (Phase 4)UnknownNCT00274885
What this trial is testing

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Who this might be right for
Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)UnknownNCT02184182
What this trial is testing

Laparoscopic Microwave Ablation and Portal Vein Ligation for Staged Hepatectomy (LAPS)

Who this might be right for
Liver Tumors
Azienda Ospedaliera di Padova 10
Next Page